Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of March 13, 2025 • 5:30 AM ET

Date/Time Source News Release
03/10/2025 04:05 PM EDT Newsfile Medicus Pharma Ltd. Announces Closing of $4.2 Million Regulation A Offering
03/06/2025 08:30 PM EST Newsfile Medicus Pharma Ltd. Announces Pricing of $4.2 Million Regulation A Offering
03/06/2025 07:30 AM EST Newsfile Medicus Pharma Ltd Announces Positively Trending Interim Analysis for SKNJCT-003 Phase 2 Clinical Study to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
02/27/2025 07:30 AM EST Newsfile Medicus Pharma Ltd Announces Submission of Phase 2 Clinical Design (SKNJCT-004) to United Arab Emirates (UAE) Department of Health (DOH) to Non-Invasively Treat Basal Cell Carcinoma of the Skin (BCC)
02/14/2025 07:30 AM EST Newsfile Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma (BCC)
02/11/2025 07:41 AM EST Newsfile Medicus Pharma Ltd. Enters into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist from the TSX Venture Exchange (TSXV)
12/12/2024 07:30 AM EST Newsfile Medicus Pharma Ltd. Announces Minor Use (MUMS) Designation from the FDA for Doxorubicin-Containing Microneedle Array (D-MNA) Patch
12/02/2024 07:30 AM EST Newsfile Medicus Pharma Ltd. Announces Collaboration Agreement to Expand Phase 2 Clinical Study in Asia Pacific Region
11/18/2024 07:30 AM EST Newsfile Medicus Pharma Ltd. Appoints Faisal Mehmud, MD, MRCP as Chief Medical Officer
11/15/2024 04:47 PM EST Newsfile Medicus Pharma Ltd. Announces Closing of US$4.0M Initial Public Offering in the United States
Page
  • 1

Additional News

As of March 13, 2025 • 5:30 AM ET

Date/Time Source News Release
02/11/2025 07:45 AM EST SeekingAlpha Medicus Pharma signs standby equity purchase agreement; announces intention to voluntarily delist from TSXV
12/24/2024 10:50 AM EST SeekingAlpha Medicus Pharma initiated at buy by Brookline Capital
12/02/2024 09:10 AM EST SeekingAlpha Medicus Pharma collaborates to expand mid-stage cancer treatment study in Asia-Pacific region
11/18/2024 07:48 AM EST SeekingAlpha Medicus Pharma appoints Faisal Mehmud as CMO
Page
  • 1

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.